Related Experiment Video
Updated: Jul 5, 2026
Establishment of Human Epithelial Enteroids and Colonoids from Whole Tissue and Biopsy
Published on: March 6, 2015
Novel delivery system for inducing quiescence in intestinal stem cells in rats by transforming growth factor beta 1
P A Puolakkainen1, J E Ranchalis, W R Gombotz
1Department of Medicine, University of Washington, Seattle.
Background/Aims:
Intestinal mucosa, a tissue in a dynamic state of rapid cellular proliferation, is often adversely affected by cytotoxic drugs. The purpose of this study was to develop an oral delivery system targeting transforming growth factor (TGF) beta 1 locally and analyze its effects on the epithelial stem cells of gastrointestinal mucosa.
Methods:
Rats were treated with recombinant TGF-beta 1 in alginate beads perorally or with recombinant TGF-beta 1 in phosphate-buffered saline perorally or intraperitoneally. Control animals received phosphate-buffered saline only. The size of the villi was measured. Proliferating and mitotic indices were determined by quantifying immunohistochemical staining for proliferating cell nuclear antigen.
Results:
Alginate beads released no TGF-beta 1 in acid. However, in pH 7.4, TGF-beta 1 was released in an active form. Histomorphometrical analysis showed a marked reduction in villus height (50%-70%) in the intestinal mucosa of animals treated perorally with recombinant TGF-beta 1 in alginate beads. Also, the proliferating and mitotic indices were significantly reduced (P < 0.01) in these animals as compared with controls and other routes of administration.
Conclusions:
This study shows that recombinant TGF-beta 1 administered using a novel oral delivery system induces stem cell quiescence in the intestinal mucosa of the rat.
Insights
A novel oral delivery system effectively targets transforming growth factor beta 1 (TGF-β1) in the intestinal mucosa. This approach induces stem cell quiescence in the gastrointestinal lining, offering a new therapeutic avenue.
Area of Science:
- Gastroenterology
- Pharmacology
- Stem Cell Biology
Background:
- The intestinal mucosa is a rapidly proliferating tissue vulnerable to cytotoxic drugs.
- Targeting gastrointestinal stem cells is crucial for managing mucosal damage.
Purpose of the Study:
- To develop an oral delivery system for local targeting of transforming growth factor beta 1 (TGF-β1).
- To analyze the effects of targeted TGF-β1 delivery on gastrointestinal epithelial stem cells.
Main Methods:
- Rats received recombinant TGF-β1 encapsulated in alginate beads orally.
- Control groups received TGF-β1 via other routes or saline.
- Villus height, proliferating, and mitotic indices were quantified.
Main Results:
- Alginate beads demonstrated pH-dependent release of active TGF-β1.
- Oral TGF-β1 in alginate beads significantly reduced villus height (50-70%).
- Proliferating and mitotic indices were significantly decreased in treated rats (P < 0.01).
Conclusions:
- A novel oral delivery system successfully administered TGF-β1 locally.
- TGF-β1 administration via this system induced stem cell quiescence in rat intestinal mucosa.
Related Concept Videos
01:23Renewal of Intestinal Stem Cells
01:12Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...